文献速递生殖医学

基于全基因组关联研究解析抗苗勒管激素与绝经年龄的共同遗传结构

Dissecting the shared genetic architecture between anti-Müllerian hormone and age at menopause based on genome-wide association study.
PubMed 文献 · Am J Obstet Gynecol · 2024-07-03

本研究利用欧洲人群全基因组关联研究汇总数据(抗苗勒管激素 N=7049,绝经年龄 N=201323),通过连锁不平衡得分回归等方法发现两者存在正遗传相关(相关系数=0.88,P=1.33×10-5),鉴定出42个多效性位点、245个多效性基因,并提示绝经年龄对抗苗勒管激素的潜在因果效应,极低密度脂蛋白为潜在中介。

要点

  • 抗苗勒管激素与绝经年龄存在正遗传相关(相关系数=0.88,P=1.33×10-5)。
  • 鉴定出42个显著多效性位点,其中10个共定位;245个显著多效性基因。
  • 两样本孟德尔随机化提示绝经年龄对抗苗勒管激素的潜在因果效应,极低密度脂蛋白为潜在中介。

核心结论

  • 抗苗勒管激素与绝经年龄存在共同遗传结构,为实验研究和个体化治疗改善生殖结局提供依据。
  • 仅依赖抗苗勒管激素不足以准确预测绝经年龄,需结合其他因素。
  • 针对共同遗传结构中的共享基因探索延缓绝经发生的新疗法具有前景。

研究设计与样本

  • 利用欧洲人群公开全基因组关联研究汇总数据:抗苗勒管激素 N=7049,绝经年龄 N=201323。
  • 采用连锁不平衡得分回归、复合零假设下多效性分析、遗传关联功能映射与注释、基因组注释多标记分析、共定位分析、基于基因型-组织表达数据的组织富集分析、基于汇总数据的孟德尔随机化、两样本孟德尔随机化及代谢物中介分析。

主要发现

  • 抗苗勒管激素与绝经年龄呈正遗传相关(相关系数=0.88,P=1.33×10-5)。
  • 鉴定出42个显著多效性位点,其中10个(rs10734411、rs61913600、rs2277339、rs75770066、rs28416520、rs9796、rs11668344、rs403727、rs6011452、rs62237617)为共定位位点。
  • 鉴定出245个显著多效性基因;遗传关联显著富集于全血、脑、心脏、肝脏、肌肉、胰腺和肾脏等组织。
  • 基于汇总数据的孟德尔随机化分析揭示9个基因可能对抗苗勒管激素和绝经年龄均有致病效应。
  • 两样本孟德尔随机化提示绝经年龄对抗苗勒管激素的潜在因果效应,极低密度脂蛋白为潜在中介。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While the phenotypic association between anti-Müllerian hormoneand age at menopause has been widely studied, the role of anti-Müllerian hormone in predicting the age at menopause is currently controversial, and the genetic architecture or causal relationships underlying these 2 traits is not well understood. AIM: We aimed to explore the shared genetic architecture between anti-Müllerian hormone and age at menopause, to identify shared pleiotropic loci and genes, and to investigate causal association and potential causal mediators. STUDY DESIGN: Using summary statistics from publicly available genome-wide association studies on anti-Müllerian hormone (N=7049) and age at menopause (N=201,323) in Europeans, we investigated the global genetic architecture between anti-Müllerian hormone and age at menopause through linkage disequilibrium score regression. We employed pleiotropic analysis under composite null hypothesis, Functional Mapping and Annotation of Genetic Associations, multimarker analysis of GenoMic annotation, and colocalization analysis to identify loci and genes with pleiotropic effects. Tissue enrichment analysis based on Genotype-Tissue Expression data was conducted using the Linkage Disequilibrium Score for the specific expression of genes analysis. Functional genes that were shared were additionally identified through summary data-based Mendelian randomization. The relationship between anti-Müllerian hormone and age at menopause was examined through 2-sample Mendelian randomization, and potential mediators were further explored using colocalization and metabolite-mediated analysis. RESULTS: A positive genetic association (correlation coefficient=0.88, P=1.33×10-5) was observed between anti-Müllerian hormone and age at menopause. By using pleiotropic analysis under composite null hypothesis and Functional Mapping and Annotation of Genetic Associations, 42 significant pleiotropic loci were identified that were associated with anti-Müllerian hormone and age at menopause, and 10 of these (rs10734411, rs61913600, rs2277339, rs75770066, rs28416520, rs9796, rs11668344, rs403727, rs6011452, and rs62237617) had colocalized loci. Additionally, 245 significant pleiotropic genes were identified by multimarker analysis of GenoMic annotation. Genetic associations between anti-Müllerian hormone and age at menopause were markedly concentrated in various tissues including whole blood, brain, heart, liver, muscle, pancreas, and kidneys. Further, summary data-based Mendelian randomization analysis revealed 9 genes that may have a causative effect on both anti-Müllerian hormone and age at menopause. A potential causal effect of age at menopause on anti-Müllerian hormone was suggested by 2-sample Mendelian randomization analysis, with very-low-density lipoprotein identified as a potential mediator. CONCLUSION: Our study revealed a shared genetic architecture between anti-Müllerian hormone and age at menopause, providing a basis for experimental investigations and individual therapies to enhance reproductive outcomes. Furthermore, our findings emphasized that relying solely on anti-Müllerian hormone is not sufficient for accurately predicting the age at menopause, and a combination of other factors needs to be considered. Exploring new therapeutics aimed at delaying at the onset of menopause holds promise, particularly when targeting shared genes based on their shared genetic architecture.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Long P, Tan H, Chen B, et al. Dissecting the shared genetic architecture between anti-Müllerian hormone and age at menopause based on genome-wide association study. Am J Obstet Gynecol. 2024. PMID: 38969199. doi:10.1016/j.ajog.2024.06.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。